275 related articles for article (PubMed ID: 28624570)
21. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
22. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
[TBL] [Abstract][Full Text] [Related]
23. Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
Spotnitz ME; Natarajan K; Ryan PB; Westhoff CL
Obstet Gynecol; 2020 Feb; 135(2):319-327. PubMed ID: 31923062
[TBL] [Abstract][Full Text] [Related]
24. Reactional changes in short-term levonorgestrel-releasing intrauterine system (lng-ius) use.
Giraldo PC; Souza TC; Henrique GL; Monteiro I; Amaral R; Machado RB; Discacciati MG; Sanches JM
Rev Assoc Med Bras (1992); 2019 Jul; 65(6):857-863. PubMed ID: 31340317
[TBL] [Abstract][Full Text] [Related]
25. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices.
Enzlin P; Weyers S; Janssens D; Poppe W; Eelen C; Pazmany E; Elaut E; Amy JJ
J Sex Med; 2012 Apr; 9(4):1065-73. PubMed ID: 21492401
[TBL] [Abstract][Full Text] [Related]
26. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
27. One-year follow up on post-placental IUD insertion: A randomized clinical trial.
Marangoni M; Laporte M; Surita F; Kraft MB; Bahamondes L; Juliato CRT
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):596-603. PubMed ID: 33421091
[TBL] [Abstract][Full Text] [Related]
28. Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study.
Roland N; Baricault B; Dray-Spira R; Weill A; Duranteau L; Zureik M
Int J Gynaecol Obstet; 2023 Feb; 160(2):594-603. PubMed ID: 36066002
[TBL] [Abstract][Full Text] [Related]
29. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
Hubacher D; Masaba R; Manduku CK; Veena V
Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
[TBL] [Abstract][Full Text] [Related]
30. Influence of contraceptive choice on vaginal bacterial and fungal microflora.
Donders G; Bellen G; Janssens D; Van Bulck B; Hinoul P; Verguts J
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):43-48. PubMed ID: 27638008
[TBL] [Abstract][Full Text] [Related]
31. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
32. The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study.
Lindh I; Milsom I
Hum Reprod; 2013 Jul; 28(7):1953-60. PubMed ID: 23578948
[TBL] [Abstract][Full Text] [Related]
33. Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model.
Hashway SA; Bergin IL; Bassis CM; Uchihashi M; Schmidt KC; Young VB; Aronoff DM; Patton DL; Bell JD
J Med Primatol; 2014 Apr; 43(2):89-99. PubMed ID: 24266633
[TBL] [Abstract][Full Text] [Related]
34. Effects of a levonorgestrel intrauterine system versus a copper intrauterine device on menstrual changes and uterine artery Doppler.
Rezk M; Elshamy E; Shaheen AE; Shawky M; Marawan H
Int J Gynaecol Obstet; 2019 Apr; 145(1):18-22. PubMed ID: 30706471
[TBL] [Abstract][Full Text] [Related]
35. Female sexual function in women using LARC methods.
Trigo ACM; Maron CC; Pinheiro MSA; da Silva SBL; Brito MB
Gynecol Endocrinol; 2022 Jan; 38(1):68-72. PubMed ID: 34672861
[TBL] [Abstract][Full Text] [Related]
36. A survey of young women's perceptions of the influence of the Levonorgestrel-Intrauterine System or copper-intrauterine device on sexual desire.
Malmborg A; Brynhildsen J; Hammar M
Sex Reprod Healthc; 2019 Oct; 21():75-80. PubMed ID: 31395237
[TBL] [Abstract][Full Text] [Related]
37. Major differences in the characteristics of users of the copper intrauterine device or levonorgestrel intrauterine system at a clinic in Campinas, Brazil.
Laporte M; Metelus S; Ali M; Bahamondes L
Int J Gynaecol Obstet; 2022 Feb; 156(2):240-246. PubMed ID: 33872406
[TBL] [Abstract][Full Text] [Related]
38. Introduction of the levonorgestrel intrauterine system in Kenya through mobile outreach: review of service statistics and provider perspectives.
Hubacher D; Akora V; Masaba R; Chen M; Veena V
Glob Health Sci Pract; 2014 Feb; 2(1):47-54. PubMed ID: 25276562
[TBL] [Abstract][Full Text] [Related]
39. Extended use of the intrauterine device: a literature review and recommendations for clinical practice.
Wu JP; Pickle S
Contraception; 2014 Jun; 89(6):495-503. PubMed ID: 24679478
[TBL] [Abstract][Full Text] [Related]
40. [Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
Gardyszewska A; Czajkowski K
Ginekol Pol; 2012 Dec; 83(12):950-2. PubMed ID: 23488301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
